
|Articles|June 15, 2003
Allergan, ACADIA to work on new drug chemistries
San Diego-ACADIA Pharmaceuticals will collaborate with Allergan Inc. to develop eye-care applications related to chemistries that ACADIA has identified for a wide range of G-protein coupled receptor and nuclear receptor targets.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Dr. Mali’s top 5 predictions in ophthalmology for 2026
2
FDA clears Novaliq’s Investigational New Drug application for NOV05
3
Eye exams could enable earlier detection of systemic disease
4
Low-dose pilocarpine shrinks pupil without altering accommodation in presbyopia
5



























